摘要
目的研究毛蕊异黄酮对氧糖剥夺/复氧复糖PC12细胞凋亡的影响。方法将对数生长期PC12细胞随机分为4组:正常对照组(Control)、模型组(Model)、毛蕊异黄酮组(Calycosin,0.07μmol·L^-1)和尼莫地平组(Nimodipine,5.00μmol·L^-1,阳性对照药组)。用CCK-8检测细胞存活率;流式细胞术和TUNEL染色检测细胞凋亡率和凋亡指数;免疫荧光染色检测细胞Bax/Bcl-2比值;Western blot检测细胞凋亡蛋白caspase-3表达。结果与Control组相比,Model组细胞存活率明显降低(P<0.05),细胞凋亡率和凋亡指数明显升高(P<0.05),Bax/Bcl-2比值和caspase-3蛋白表达明显升高(P<0.05);与Model组相比,Calycosin组和Nimodipine组细胞存活率均明显升高(P<0.05),细胞凋亡率和凋亡指数均明显降低(P<0.05),Bax/Bcl-2比值和caspase-3蛋白表达均明显降低(P<0.05),差异有统计学意义。结论毛蕊异黄酮可明显提高氧糖剥夺/复氧复糖PC12细胞存活率,抑制细胞凋亡,其作用机制与毛蕊异黄酮调控凋亡蛋白Bax、Bcl-2、caspase-3表达有关。
Aim To study the effect of calycosin on apoptosis of PC12 cells under oxygen and glucose deprivation/reoxygenation.Methods PC12 cells in logarithmic phase were randomly divided into four groups:normal control group,model group,calycosin group(0.07μmol·L^-1)and nimodipine group(5.00 micromol L-1,positive control group).CCK-8 assay was used to detect cell survival rate;flow cytometry and TUNEL staining were used to detect apoptotic rate and apoptotic index;immunofluorescence staining was used to detect Bax/Bcl-2 ratio;Western blot was used to detect the expression of caspase-3 apoptotic protein.Results Compared with control group,the cell survival rate significantly declined(P<0.05),the apoptotic rate and apoptotic index significantly rose(P<0.05),and Bax/Bcl-2 ratio and caspase-3 protein expression were significantly up-regulated(P<0.05);compared with model group,the cell survival rate significantly increased in calycosin group and nimodipine group(P<0.05),the mortality and apoptotic index significantly decreased(P<0.05),the Bax/Bcl-2 ratio and caspase-3 protein expression significantly decreased(P<0.05),and the difference was statistically significant.Conclusions Calycosin can significantly improve the survival rate of oxygen-glucose deprivation/reoxygenation PC12 cells and inhibit cell apoptosis.Its mechanism is related to the regulation of expression of apoptotic proteins Bax,Bcl-2 and caspase-3 by calycosin.
作者
张彐宁
靳晓飞
周晓红
张颖
高维娟
ZHANG Xue-ning;JIN Xiao-fei;ZHOU Xiao-hong;ZHANG Ying;GAO Wei-juan(Hebei University of Chinese Medicine,Hebei Key Lab of Chinese Medicine Research on Cardio-cerebrovascular Disease,Shijiazhuang 050091,China)
出处
《中国药理学通报》
CAS
CSCD
北大核心
2019年第12期1693-1698,共6页
Chinese Pharmacological Bulletin
基金
国家自然科学基金面上项目(No 81873180)
河北省教育厅青年基金项目(No QN2018059)
河北省中医药管理局科研计划项目(No 2019093)
河北省研究生创新资助项目(No CXZZSS2019066)
河北中医学院优秀青年教师基础研究计划项目(No YQ2018005)
河北中医学院青年教师科研基金项目(No QNZ2018001)